Royalty Pharma plcRoyalty Pharma plcRoyalty Pharma plc

Royalty Pharma plc

No trades
See on Supercharts
Market capitalization
‪16.50 B‬USD
‪1.13 B‬USD
‪2.35 B‬USD
‪378.53 M‬
Beta (1Y)
0.85

About Royalty Pharma plc

CEO
Pablo Gerardo Legorreta
Headquarters
New York
Employees (FY)
89
Founded
2020
ISIN
GB00BMVP7Y09
FIGI
BBG00V1L5YZ5
Royalty Pharma Plc provides drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RPRX is 27.89 USD — it has increased by 1.01% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Royalty Pharma plc stocks are traded under the ticker RPRX.
Royalty Pharma plc is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
RPRX stock is 1.95% volatile and has beta coefficient of 0.85. Check out the list of the most volatile stocks — is Royalty Pharma plc there?
One year price forecast for Royalty Pharma plc has a max estimate of 50.00 USD and a min estimate of 37.00 USD.
RPRX earnings for the last quarter are 0.79 USD whereas the estimation was 0.77 USD which accounts for 2.49% surprise. Estimated earnings for the next quarter are 1.01 USD. See more details about Royalty Pharma plc earnings.
Royalty Pharma plc revenue for the last quarter amounts to ‪637.00 M‬ USD despite the estimated figure of ‪631.74 M‬ USD. In the next quarter revenue is expected to reach ‪685.52 M‬ USD.
Yes, you can track Royalty Pharma plc financials in yearly and quarterly reports right on TradingView.
RPRX stock has fallen by 5.55% compared to the previous week, the month change is a 7.13% fall, over the last year Royalty Pharma plc has showed a 21.90% decrease.
RPRX net income for the last quarter is ‪495.00 M‬ USD, while the quarter before that showed ‪72.11 M‬ USD of net income which accounts for 586.41% change. Track more Royalty Pharma plc financial stats to get the full picture.
Today Royalty Pharma plc has the market capitalization of ‪12.33 B‬, it has decreased by 0.68% over the last week.
Yes, RPRX dividends are paid quarterly. The last dividend per share was 0.21 USD. As of today, Dividend Yield (TTM)% is 2.93%. Tracking Royalty Pharma plc dividends might help you take more informed decisions.
Royalty Pharma plc dividend yield was 2.85% in 2023, and payout ratio reached 31.57%. The year before the numbers were 1.92% and 777.10% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, RPRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Royalty Pharma plc stock right from TradingView charts — choose your broker and connect to your account.
RPRX reached its all-time high on Jun 18, 2020 with the price of 56.50 USD, and its all-time low was 25.92 USD and was reached on Sep 21, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 89.00 employees. See our rating of the largest employees — is Royalty Pharma plc on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Royalty Pharma plc technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Royalty Pharma plc stock shows the strong sell signal. See more of Royalty Pharma plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Royalty Pharma plc future price: according to them, RPRX price has a max estimate of 50.00 USD and a min estimate of 37.00 USD. Read a more detailed Royalty Pharma plc forecast: see what analysts think of Royalty Pharma plc and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Royalty Pharma plc EBITDA is ‪1.49 B‬ USD, and current EBITDA margin is 63.37%. See more stats in Royalty Pharma plc financial statements.